2018 IDWeek, the Co-morbidities and Adverse Drug Reactions Workshop, and Glasgow*

IDWeek 2018; October 3-7, 2018; San Francisco, California
20th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV; October 13-14, 2018; New York, New York
HIV Drug Therapy Glasgow 2018; October 28-31, 2018; Glasgow, United Kingdom
Review the latest clinical findings from 3 important HIV meetings.
Daniel R. Kuritzkes, MD
Peter Reiss, MD, PhD
Babafemi Taiwo, MBBS
David A. Wohl, MD

Downloadable Audio

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty assessed how new HIV data reported at fall 2018 conferences will affect clinical practice and answered questions from participants.

David A. Wohl, MD Released: November 12, 2018


Preclinical and early-phase clinical data are promising for the novel HIV capsid inhibitor GS-6207 and the NRTTI MK-8591. What roles could these long-acting injectables potentially serve in our treatment armamentarium?

Babafemi Taiwo, MBBS Released: November 27, 2018

Concerning data from an ongoing study evaluating ART exposure during pregnancy underscore the need for more research on drug safety in early pregnancy. How do the results of other ART pregnancy safety analyses reported this fall contribute to the existing body of knowledge?

Daniel R. Kuritzkes, MD Released: December 13, 2018

What switch options can we offer to our patients with stable virologic suppression on older, more cumbersome ART regimens? Data from IAS, IDWeek, and Glasgow 2018 support novel booster-free options, including 2- and 3-drug combinations based on recently approved agents.

David A. Wohl, MD Released: January 23, 2019

Downloadable Slideset

In this downloadable slideset, CCO’s expert faculty members provide an insightful review of the most clinically relevant new HIV data reported at 3 Fall 2018 conferences.

Peter Reiss, MD, PhD Babafemi Taiwo, MBBS Released: November 14, 2018
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Educational grants provided by
Gilead Sciences
Janssen Therapeutics
ViiV Healthcare

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?